<html>
<head>PUBMED IDs for CD204</head>
<body bgcolor='#C5F0F2'><h1>CD204</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21460221/'>Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.</a> July 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21595824/'>Extracellular matrix remodelling properties of human fibrocytes.</a> June 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21832164/'>CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.</a> November 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22083206/'>Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell.</a> August 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22842565/'>Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.</a> December 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22896667/'>In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.</a> April 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22896656/'>Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.</a> June 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22896655/'>Clinicopathologic features and long-term outcomes of NUT midline carcinoma.</a> May 25  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24278429/'>Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.</a> January 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24981452/'>IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.</a> September 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24981438/'>Charting a clear path: the ASGCT Standardized Pathways Conference.</a> February 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25620088/'>Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.</a> December 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25730371/'>GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.</a> August 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26001293/'>High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.</a> July 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26918621/'>Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma.</a> February 9  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26918607/'>Analysis of differential β variable region of T cell receptor expression and NAV3/TNFRSF1B gene mutation in mycosis fungoides.</a> February 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27601677/'>Gene-expression profiling of different arms of lymphatic vasculature identifies candidates for manipulation of cell traffic.</a> September 8  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27690238/'>CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.</a> October 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27761967/'>Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.</a> October 21  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28406993/'>Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.</a> April 22  2017<br></body></html>
